Literature DB >> 11336696

The large subunit of replication factor C promotes cell survival after DNA damage in an LxCxE motif- and Rb-dependent manner.

V Pennaneach1, I Salles-Passador, A Munshi, H Brickner, K Regazzoni, F Dick, N Dyson, T T Chen, J Y Wang, R Fotedar, A Fotedar.   

Abstract

Retinoblastoma (Rb) protein promotes cell survival after DNA damage. We show here that the LxCxE binding site in Rb mediates both cell survival and cell-cycle arrest after DNA damage. Replication factor C (RF-C) complex plays an important role in DNA replication. We describe a novel function of the large subunit of RF-C in promoting cell survival after DNA damage. RF-Cp145 contains an LxCxE motif, and mutation of this motif abolishes the protective effect of RF-Cp145. The inability of wild-type RF-Cp145 to promote cell survival in Rb-null cells is rescued by Rb but not by Rb mutants defective in binding LxCxE proteins. RF-C thus enhances cell survival after DNA damage in an Rb-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336696     DOI: 10.1016/s1097-2765(01)00217-9

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  23 in total

1.  RB reversibly inhibits DNA replication via two temporally distinct mechanisms.

Authors:  Steven P Angus; Christopher N Mayhew; David A Solomon; Wesley A Braden; Michael P Markey; Yukiko Okuno; M Cristina Cardoso; David M Gilbert; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

2.  cAMP-mediated inhibition of DNA replication and S phase progression: involvement of Rb, p21Cip1, and PCNA.

Authors:  Soheil Naderi; Jean Y J Wang; Tung-Ti Chen; Kristine B Gutzkow; Heidi K Blomhoff
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

3.  Photoaffinity isolation and identification of proteins in cancer cell extracts that bind to platinum-modified DNA.

Authors:  Evan R Guggenheim; Dong Xu; Christiana X Zhang; Pamela V Chang; Stephen J Lippard
Journal:  Chembiochem       Date:  2009-01-05       Impact factor: 3.164

Review 4.  Multifaceted regulation and functions of replication factor C family in human cancers.

Authors:  Yanling Li; Sijie Gan; Lin Ren; Long Yuan; Junlan Liu; Wei Wang; Xiaoyu Wang; Yi Zhang; Jun Jiang; Fan Zhang; Xiaowei Qi
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

5.  Inactivation of CtIP leads to early embryonic lethality mediated by G1 restraint and to tumorigenesis by haploid insufficiency.

Authors:  Phang-Lang Chen; Feng Liu; Suna Cai; Xiaoqin Lin; Aihua Li; Yumay Chen; Bingnan Gu; Eva Y-H P Lee; Wen-Hwa Lee
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

Review 6.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

7.  Distinct action of the retinoblastoma pathway on the DNA replication machinery defines specific roles for cyclin-dependent kinase complexes in prereplication complex assembly and S-phase progression.

Authors:  Wesley A Braden; Jon M Lenihan; Zhengdao Lan; K Scott Luce; William Zagorski; Emily Bosco; Michael F Reed; Jeanette G Cook; Erik S Knudsen
Journal:  Mol Cell Biol       Date:  2006-08-14       Impact factor: 4.272

8.  Tumor suppression by a severely truncated species of retinoblastoma protein.

Authors:  Hong Yang; Bart O Williams; Phillip W Hinds; T Shane Shih; Tyler Jacks; Roderick T Bronson; David M Livingston
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

Review 9.  The rb pathway and cancer therapeutics.

Authors:  W Du; J S Searle
Journal:  Curr Drug Targets       Date:  2009-07       Impact factor: 3.465

10.  Interaction of the retinoblastoma protein with Orc1 and its recruitment to human origins of DNA replication.

Authors:  Ramiro Mendoza-Maldonado; Roberta Paolinelli; Laura Galbiati; Sara Giadrossi; Mauro Giacca
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.